中华内分泌外科杂志
中華內分泌外科雜誌
중화내분비외과잡지
CHINESE JOURNAL OF ENDOCRINE SURGERY
2011年
3期
152-154,169
,共4页
乳腺癌%Survivin%PR%ER%Her-2
乳腺癌%Survivin%PR%ER%Her-2
유선암%Survivin%PR%ER%Her-2
Breast cancer%Survivin%PR%ER%Her-2
目的 观察凋亡抑制基因survivin在乳腺癌组织的表达及其与临床各参数的关系,探讨survivin基因在乳腺癌发生中的作用及其与乳腺癌预后的关系.方法 采用Western blot方法检测survivin基因在50例乳腺癌组织、50例乳腺癌旁组织、20例正常乳腺组织标本中的蛋白表达.结果 50例乳腺癌组织中38例survivin表达阳性,50例乳腺癌旁组织中11例survivin表达阳性,20例正常乳腺组织无survivin蛋白表达,survivin蛋白阳性表达与乳腺癌的腋窝淋巴结转移有关,而与PR、ER和Her-2及患者年龄无关.结论 survivin在乳腺癌发生中起重要作用,是乳腺癌患者临床预后的重要参数之一.
目的 觀察凋亡抑製基因survivin在乳腺癌組織的錶達及其與臨床各參數的關繫,探討survivin基因在乳腺癌髮生中的作用及其與乳腺癌預後的關繫.方法 採用Western blot方法檢測survivin基因在50例乳腺癌組織、50例乳腺癌徬組織、20例正常乳腺組織標本中的蛋白錶達.結果 50例乳腺癌組織中38例survivin錶達暘性,50例乳腺癌徬組織中11例survivin錶達暘性,20例正常乳腺組織無survivin蛋白錶達,survivin蛋白暘性錶達與乳腺癌的腋窩淋巴結轉移有關,而與PR、ER和Her-2及患者年齡無關.結論 survivin在乳腺癌髮生中起重要作用,是乳腺癌患者臨床預後的重要參數之一.
목적 관찰조망억제기인survivin재유선암조직적표체급기여림상각삼수적관계,탐토survivin기인재유선암발생중적작용급기여유선암예후적관계.방법 채용Western blot방법검측survivin기인재50례유선암조직、50례유선암방조직、20례정상유선조직표본중적단백표체.결과 50례유선암조직중38례survivin표체양성,50례유선암방조직중11례survivin표체양성,20례정상유선조직무survivin단백표체,survivin단백양성표체여유선암적액와림파결전이유관,이여PR、ER화Her-2급환자년령무관.결론 survivin재유선암발생중기중요작용,시유선암환자림상예후적중요삼수지일.
Objective To investigate the expression of snrvivin,an anti-apoptosis gene,in breast cancer tissues and its relationship with clinical parameters of breast cancer patients.To investigate the role of survivin in oncogenesis of breast cancer and its relation with prognosis of breast cancer.Methods Western blot was conducted to detect survivin expression in cancerous tissues and adjacent tissues of 50 breast cancer patients.20 normal breast tissue samples were used as control.Results Survivin was expressed in 38 of the 50 breast cancer tissues (76.0%)and in 11 of 50 breast adjacent normal tissues(22.0%)while no expression was found in normal tissues.The positive protein expression of survivin was related to axillary lymph node metastasis of breast cancer while it was not related to expression of PR,ER,Her-2 or ages of patients.Conclusion Survivin may play a role in breast tumorigenesis and is an important predictive parameter in breast cancer patients.